Lead the clinical development strategy for AL137, owning the medical strategy for Phase 1 and shaping the path toward later-stage development.
Provide medical leadership for protocol design, safety considerations, dose escalation, and data interpretation in early clinical trials.
Serve as the internal physician expert, integrating AI technologies to accelerate analysis and improve decision-making.
Alector develops therapies that empower the immune system to combat neurodegeneration. The company is supported by experienced scientists, leading healthcare investors, and pharma partners, fostering a dynamic and flexible culture that encourages experimentation and ownership.
Serve as senior physician for CAR T-cell therapy clinical trials in autoimmune indications providing medical oversight across study design and execution.
Lead clinical development plans and study execution for neuroimmunology and autoimmune disease programs.
Contribute to scientific communication and external engagement with key opinion leaders and regulatory authorities.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It is guided by core values including collaboration and innovation, and is committed to transforming treatment for autoimmune diseases.
Define and execute the clinical platforms roadmap and lead end-to-end product development.
Oversee platform operations, PMO governance, and delivery execution across teams and vendors.
Partner with clinical and commercial teams to position platforms as differentiated and scalable.
Fortrea is a global contract research organization supporting the development of life-saving therapies through clinical trial services. With a large, global team, Fortrea fosters a collaborative culture focused on innovation and patient-centric delivery.
Set clinical validation standards for new features, workflows, interventions, and AI-supported experiences before and after launch.
Bring the clinical lens to feature assessment alongside Product, calibrating the level of clinical rigor to the actual risk of each feature.
Monitor and interpret clinical outcomes to identify drivers of improvement, decline, or variation, and direct program, protocol, product, workflow, or training changes in response.
Sword is building AI to heal billions and unlock humanity’s full potential, pioneering a fundamentally new approach to healthcare called AI Care. Since 2020, Sword has expanded across multiple health areas, serving over 1 million members, 2,000+ enterprise clients, and backed by $500 million from leading investors.
Own a list of target clinics, research each account, and spend time on the phone.
Respond fast when a clinic shows interest and qualify honestly before passing leads.
Own your outbound workflow in Unify and help write the playbook for future hires.
We are a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. We are a 50-person, Series B-stage company backed by top investors like DFJ Growth, Y Combinator, and General Catalyst.
Support operational execution of clinical studies from initial synopsis through final deliverables.
Manage implementation, on-time execution, and conduct of clinical studies, including budget and vendor management.
Oversee cross-functional study teams and ensure compliance with regulations and data integrity.
Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are committed to continuous innovation in cell therapy.
Provides strategic and scientific leadership for patient-centered outcomes engagements, ensuring research design and evidence packages are fit-for-purpose.
Owns client relationships, drives business development, and leads proposal development to achieve revenue and sales targets.
Oversees clinical outcome assessment projects including literature reviews, gap analyses, regulatory strategy, and dossier development.
Lumanity is a global strategic partner that brings together strategy, evidence, engagement, and technology to improve health outcomes. The company is dedicated to accelerating and optimizing access to life-changing medicines.
Drive strategic growth of Celerion's Bioanalytical Services business through new client acquisition in biologics, biomarkers, and emerging therapeutic modalities.
Serve as a technical commercial leader combining scientific credibility with consultative selling to develop new client relationships.
Collaborate with regional Business Development teams and manage a national opportunity pipeline to expand presence with biotech and pharma companies.
Celerion is a clinical research organization that accelerates drug development through translational medicine and innovative research strategies. The company values integrity, trust, teamwork, and respect, operating with experienced professionals across the US.
Supports clinical trial design, protocol development, and data interpretation to ensure high-quality data generation.
Provides medical expertise in therapeutic areas, reviews safety data, and contributes to regulatory documents.
Collaborates cross-functionally with clinical operations, regulatory affairs, and other teams to align clinical activities with development plans.
Oruka Therapeutics is developing novel biologics for chronic skin diseases. As a publicly traded biotechnology company with a startup culture, it focuses on offering patients greater freedom from conditions like plaque psoriasis.
You will develop clinical imaging and dosimetry strategies to support clinical development plans for ARTBIO's RLT agents.
You will design and implement imaging protocols, procedures, and standards for clinical studies, including quantitative imaging and dosimetry oversight.
You will provide oversight for site imaging, vendor management, and regulatory interactions, contributing to IND/CTA submissions and scientific presentations.
ARTBIO redefines cancer care by discovering and developing a new class of Alpha Radioligand Therapies (ARTs) powered by unique Pb-212 isotope technology. It is a global biotech with locations in Boston, Basel, London, and Oslo, offering a collaborative, supportive culture and competitive compensation.
Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation, integrating competitive positioning and biomarker strategy.
Translate Recursion OS and ClinTech insights into strategic advantages, ensuring proprietary data and computational insights maximally enable drug discovery and development.
Partner with functional leaders across clinical development, BD, finance, and platform teams to align resource allocation with strategic conviction and impact.
Recursion is a clinical-stage TechBio company decoding biology to improve lives, advancing a pipeline of investigational medicines across oncology, rare disease, neuroscience, and immunology. The company uses its AI-native Recursion OS platform and employs a team fluent in both science and AI, with offices in Salt Lake City, Oxfordshire, New York, Montréal, and London.
Own member growth and hit enrollment targets across Maven's core business as the cross-functional control tower.
Build and scale the enrollment engine from eligible population to activated member across launches and acquisition.
Lead central operations, strategy & ops, and AI enablement to raise analytical rigor and operational discipline.
Maven Clinic is the world's largest virtual clinic for women and families, offering end-to-end healthcare programs through employer and health plan partnerships. Founded in 2014, it has raised $425M and earned numerous awards for its innovative, mission-driven culture.